National Institute of Allergy and Infectious Diseases

Contact
www3.niaid.nih.gov

National Institute of Allergy and Infectious Diseases (NIAID)

6610 Rockledge Drive
20892-6612 Bethesda
USA
www3.niaid.nih.gov
Contact
Profile News
Contact

About National Institute of Allergy and Infectious Diseases

The National Institute of Allergy and Infectious Diseases (NIAID) conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. For more than 60 years, NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States and around the world.

Read more about National Institute of Allergy and Infectious Diseases
Facts about National Institute of Allergy and Infectious Diseases
  • Industry : Healthcare

News about National Institute of Allergy and Infectious Diseases

National Institute of Allergy and Infectious Diseases

27-Feb-2020 | science

NIH clinical trial of remdesivir to treat COVID-19 begins

A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed ...

Read news
National Institute of Allergy and Infectious Diseases

17-Feb-2020 | science

Remdesivir prevents MERS coronavirus disease in monkeys

Results support testing antiviral against 2019 novel coronavirus

Read news
National Institute of Allergy and Infectious Diseases

18-Oct-2019 | science

Scientists work toward a rapid point-of-care diagnostic test for Lyme disease

A study published in the Journal of Clinical Microbiology describes a new rapid assay for Lyme disease that could lead to a practical test for use by ...

Read news
National Institute of Allergy and Infectious Diseases

28-Jan-2019 | science

Investigational monoclonal antibody to treat Ebola is safe in adults

The investigational Ebola treatment mAb114 is safe, well-tolerated, and easy to administer, according to findings from an early-stage clinical trial. ...

Read news
National Institute of Allergy and Infectious Diseases

16-Jul-2018 | science

A 3D structure of 1918 influenza virus-like particles

Virus-like particles (VLPs) are protein-based structures that mimic viruses and bind to antibodies. Because VLPs are not infectious, they show considerable ...

Read news
National Institute of Allergy and Infectious Diseases

07-May-2018 | science

Essential malaria parasite genes revealed

NIAID-funded research could aid antimalarial drug development

Read news
National Institute of Allergy and Infectious Diseases

10-Apr-2018 | science

Research offers clues for improved influenza vaccine design

Influenza vaccines that better target the influenza surface protein called neuraminidase (NA) could offer broad protection against various influenza virus ...

Read news
National Institute of Allergy and Infectious Diseases

09-Oct-2017 | science

Monoclonal Antibodies Against Zika Show Promise in Monkey Study

Using blood samples from an individual previously infected with Zika virus, scientists funded by the National Institute of Allergy and Infectious Diseases ...

Read news
Show more news about National Institute of Allergy and Infectious Diseases

Here you will find National Institute of Allergy and Infectious Diseases (NIAID)